戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ted Castleman disease manifests with diffuse mediastinal lymphadenopathy.
2   At CT, all lesions manifested with diffuse mediastinal lymphadenopathy.
3 ilar lymphadenopathy, mediastinal masses, or mediastinal lymphadenopathy.
4 One patient with a mediastinal mass also had mediastinal lymphadenopathy.
5 ary lesions in the lungs along with necrotic mediastinal lymphadenopathy.
6 pital for examination of bilateral hilar and mediastinal lymphadenopathy.
7 nic space-occupying lesions (35%); abdominal/mediastinal lymphadenopathy (20%), ocular disease (18%)
8 nic space-occupying lesions (35%), abdominal/mediastinal lymphadenopathy (20%), ocular disease (18%),
9 aging may demonstrate central hilar (85%) or mediastinal lymphadenopathy (75%).
10 ings outside the parenchymal lung, including mediastinal lymphadenopathy and pericardial effusion, sh
11 he extent and type of pulmonary involvement, mediastinal lymphadenopathy, and pleural effusion were a
12             Subpleural round consolidations, mediastinal lymphadenopathy, and unilateral pleural flui
13                       Patients with isolated mediastinal lymphadenopathy (IML) are a common presentat
14  FDG-PET also accurately characterized hilar/mediastinal lymphadenopathy in 12 patients with associat
15 phagia who was found to have infiltration of mediastinal lymphadenopathy into the esophageal wall sec
16               Transthoracic needle biopsy of mediastinal lymphadenopathy is a safe, accurate diagnost
17                       EUS detected malignant mediastinal lymphadenopathy more frequently in patients
18  and more interlobular septal thickening and mediastinal lymphadenopathy on computed tomography of th
19 enty-six patients with NSCLC with absence of mediastinal lymphadenopathy on CT were enrolled and foll
20 rasound (EUS) in staging NSCLC in absence of mediastinal lymphadenopathy on CT.
21 rdial delayed enhancement of the septum, and mediastinal lymphadenopathy should raise the suspicion f
22 osed in 5 of 77 patients (6.5%), while hilar/mediastinal lymphadenopathy was found in 25 of 76 patien
23 In 29 patients, endoscopic US-guided FNAB of mediastinal lymphadenopathy was performed as a component
24 rdial delayed enhancement of the septum, and mediastinal lymphadenopathy were more often see in those
25          Subpleural round consolidations and mediastinal lymphadenopathy were typical findings on com
26         Eighty-six consecutive patients with mediastinal lymphadenopathy who did not have a primary g
27 o guide TBNA in 12 consecutive patients with mediastinal lymphadenopathy who had previously undergone
28 (PET) scan confirmed the lung lesion and the mediastinal lymphadenopathy without distant metastases.